Biodegradable Microneedles Offer New Solutions for Drug Delivery and Obesity Treatment

Biodegradable Microneedles: A Breakthrough in Drug Delivery

Transdermal drug delivery (TDD) has emerged as a non-invasive alternative to injections and oral medications, offering sustained, localized drug release with fewer side effects. Recent research takes this a step further by developing biodegradable microneedles (MNs) made from advanced biopolymers for controlled drug delivery in conditions like obesity, diabetes, and metabolic disorders.

This study assessed the biodegradation profiles of various polymeric microneedles and tested implantation methods to identify the most effective approach for safe, long-lasting, and patient-friendly therapies.

Key Findings from the Study

1. PLGA Microneedles Showed Superior Biodegradation

Microneedles were fabricated using 3D-printed molds filled with polymers like PLGA, PLA, DL-PLA, and PDLLA.

PLGA microneedles degraded completely over 168 hours, ensuring safe drug release and leaving no residues.
DL-PLA and PDLLA microneedles degraded more slowly, offering options for tailored release profiles.

2. 3D Printing Enables Precision Design

The study used high-resolution 3D printing to create microneedle molds with precise pyramidal geometries for accurate drug loading and mechanical strength.

3. Universal Harness Outperformed Surgical Implantation

Two implantation methods were compared:

Surgical suturing caused inflammation and required longer anesthesia.
Universal harness fixation was minimally invasive, provided stable skin contact, and avoided inflammatory complications.

4. Applications Beyond Obesity Treatment

While the study focused on localized delivery of obesity drugs to induce browning of white adipose tissue for weight loss, biodegradable microneedles hold potential for:

Vaccines
Hormone therapies
Pain management drugs
Chronic disease treatments

Why Biodegradable Microneedles Matter for Medicine

Patient Comfort: Minimally invasive, pain-free, and self-administered.
Safety: Complete biodegradation eliminates the risk of needle fragments.
Efficiency: Localized, sustained release reduces systemic side effects.
Versatility: Suitable for small molecules, peptides, and biologics.

Conclusion: Toward Next-Generation Drug Delivery Systems

This research demonstrates that PLGA-based biodegradable microneedles offer a safe, effective, and scalable approach for transdermal drug delivery.

By combining 3D printing technology with biopolymer science, these systems could revolutionize treatments for obesity, chronic diseases, and preventive medicine, bringing us closer to personalized, patient-friendly therapeutics.

Reference

Edemskaya, E. V, Zasypkin, G. G., Podyacheva, E. Yu., Toropova, Y. G., & Korolev, D. V. (2025). An Assessment of the Biodegradation of Microneedles and Methods of Their Implantation for Transdermal Drug Administration. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-025-06496-7